Top compounds associated with response to OR2D2


Feature Type Standardized
Nominal ANOVA
mRNA T0901317 GDSC1000 pan-cancer AAC 0.024 0.5
mRNA momelotinib CTRPv2 pan-cancer AAC 0.025 0.5
mRNA Gemcitabine GDSC1000 pan-cancer AAC -0.026 0.5
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.022 0.5
mRNA ATRA CTRPv2 pan-cancer AAC -0.025 0.5
mRNA IPA-3 GDSC1000 pan-cancer AAC -0.024 0.5
mRNA Epothilone B GDSC1000 pan-cancer AAC -0.025 0.5
mRNA Gefitinib GDSC1000 pan-cancer AAC -0.024 0.5
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC 0.023 0.5
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC 0.024 0.5
Download CSV